CompletedNCT01431326
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Studying Epilepsy syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Daniel Benjamin
- Principal Investigator
- Chi Hornik, PharmDDuke University
- Intervention
- The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:(drug)
- Enrollment
- 3520 enrolled
- Eligibility
- 21 years · All sexes
- Timeline
- 2011 – 2019
Study locations (30)
- Alaska Native Medical Center, Anchorage, Alaska, United States
- Arkansas Children's Hospital, Little Rock, Arkansas, United States
- University of California at San Diego Medical Center, La Jolla, California, United States
- Axis Clinical Trials, Los Angeles, California, United States
- University of California, Los Angeles Medical Center, Los Angeles, California, United States
- The Children's Hospital Colorado, Aurora, Colorado, United States
- Yale New Haven Children's Hospital, New Haven, Connecticut, United States
- Alfred I. DuPont Hospital for Children, Wilmington, Delaware, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- University of Florida Jacksonville Shands Medical Center, Jacksonville, Florida, United States
- Kapiolani Womens and Childrens Medical Center, Honolulu, Hawaii, United States
- Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- Riley Hospital for Children at Indiana University, Indianapolis, Indiana, United States
- University of Kansas Medical Center, Fairway, Kansas, United States
- Children's Mercy Hospital and Clinics, Kansas City, Kansas, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · The Emmes Company, LLC
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01431326 on ClinicalTrials.govOther trials for Epilepsy syndrome
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07555171EEG Dynamics in Lennox-Gastaut Syndrome Patients Undergoing Fenfluramine TreatmentUniversity of Chicago
- RECRUITINGPHASE1, PHASE2NCT07531745ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet SyndromeIonis Pharmaceuticals, Inc.
- RECRUITINGPHASE3NCT07234695LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down SyndromeFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- RECRUITINGNCT06967727Registry and Natural History of Epilepsy-Dyskinesia SyndromesBoston Children's Hospital
- RECRUITINGNCT07202494Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy AgingAssistance Publique Hopitaux De Marseille
- RECRUITINGNCT05524493High-field MR Imaging in Migraine, Visual Snow and EpilepsyUniversity of Zurich
- RECRUITINGNANCT06847152Spatial Memory and Temporal Lobe EpilepsyCentre Hospitalier Metropole Savoie
- RECRUITINGNANCT06813612Effect of Cognitive Behavioral Play Intervention and EpilepsyIRCCS National Neurological Institute "C. Mondino" Foundation